O'Shaughnessy Joyce,...,Cvetanovic Ana S,...,Stamatovic Ljiljana (2025) Long-Term Safety and Efficacy of the Fixed-Dose Combination of Pertuzumab and Trastuzumab for Subcutaneous Injection in Patients With HER2-Positive Early Breast Cancer in PHranceSCa, a Randomized, Open-Label Phase II Study, CLINICAL BREAST CANCER, vol. 25, br. 6, str. - (Article) 

Geyer Jr Charles E,...,Stamatovic Ljiljana,...,(broj koautora 34) (2025) Survival with Trastuzumab Emtansine in Residual HER2-Positive Breast Cancer, NEW ENGLAND JOURNAL OF MEDICINE, vol. 392, br. 3, str. 249-257 (Article) 

Geyer Jr Charles E,...,Stamatovic Ljiljana,...,(broj koautora 35) (2025) Survival with Trastuzumab Emtansine in Residual HER2-Positive Breast Cancer, NEW ENGLAND JOURNAL OF MEDICINE, vol. , br. , str. - (Article; Early Access) 

O'Shaughnessy Joyce,...,Cvetanovic Ana S,...,Stamatovic Ljiljana (2021) Original Research Preference for the fixed-dose combination of pertuzumab and trastuzumab for subcutaneous injection in patients with HER2-positive early breast cancer (PHranceSCa): A randomised, open-label phase II study, EUROPEAN JOURNAL OF CANCER, vol. 152, br. , str. 223-232 (Article) 

O'Shaughnessy Joyce,...,Cvetanovic Ana S,...,Stamatovic Ljiljana (2020) Patient (pt) preference for the pertuzumab-trastuzumab fixed-dose combination for subcutaneous use (PH FDC SC) in HER2-positive early breast cancer (EBC): Primary analysis of the open-label, randomised crossover PHranceSCa study, ANNALS OF ONCOLOGY, vol. 31, br. , str. S306-S307 (Meeting Abstract) 

Belkacemi Yazid,...,Tesanovic Dusanka D,...,Popovic Lazar S,...,Kovcin Vladimir N,...,Dzodic Radan R,Markovic Ivan Z,Vasovic Suzana,Stamatovic Ljiljana,Radosavljevic Davorin Z,Radulovic Sinisa S,...,(broj koautora 48) (2020) A review of the international early recommendations for departments organization and cancer management priorities during the global COVID-19 pandemic: applicability in low- and middle-income countries, EUROPEAN JOURNAL OF CANCER, vol. 135, br. , str. 130-146 (Review) 

O'Shaughnessy Joyce,...,Cvetanovic Ana S,...,Stamatovic Ljiljana (2020) Patient (pt) preference and satisfaction with the subcutaneous fixed-dose combination of pertuzumab (P) and trastuzumab (H) in pts with HER2-positive early breast cancer (HER2+eBC): Interim analysis of the open-label, randomised cross-over PHranceSCa study, ANNALS OF ONCOLOGY, vol. 31, br. , str. S42-S42 (Meeting Abstract) 

Conte Pier Franco,...,Stamatovic Ljiljana,...,(broj koautora 21) (2020) Patient-reported outcomes from KATHERINE: A phase 3 study of adjuvant trastuzumab emtansine versus trastuzumab in patients with residual invasive disease after neoadjuvant therapy for human epidermal growth factor receptor 2-positive breast cancer, CANCER, vol. 126, br. 13, str. 3132-3139 (Article) 

Todorovic Vladimir,...,Babovic Nada Lj,...,Cetnikovic Bojana,Ceric Timur,...,Dzamic Zoran M,Dzodic Radan R,Eri Zivka,...,Knezevic-Usaj Slavica F,Kovcin Vladimir N,...,Markovic Ivan Z,Markovic Milan,Mijalkovic Nenad,...,Pantelic Aleksandra,Popovic Lazar S,Radosavljevic Davorin Z,...,Radulovic Sinisa S,...,Rosic Ivana,...,Stamatovic Ljiljana,...,Tesanovic Dusanka D,Tomasevic Zorica I,Tomasevic Zoran M,...,Vasovic Suzana,Vicko Ferenc,...,Zaric Bojan,...,(broj koautora 65) (2019) AROME-ESO Oncology Consensus Conference: access to cancer care innovations in countries with limited resources. Association of Radiotherapy and Oncology of the Mediterranean Area (AROME-Paris) and European School of Oncology (ESO - Milan), JOURNAL OF BUON, vol. 24, br. 5, str. 2180-2197 (Article) 

Schneeweiss Andreas,...,Stamatovic Ljiljana,...,(broj koautora 20) (2019) Patient-reported outcomes (PROs) from KATHERINE: A phase III study of adjuvant trastuzumab emtansine (T-DM1) versus trastuzumab (H) in patients (pts) with residual invasive disease after neoadjuvant therapy for HER2-positive breast cancer., JOURNAL OF CLINICAL ONCOLOGY, vol. 37, br. 15, str. - (Meeting Abstract) 

Stamatovic Ljiljana,Susnjar Snezana V,Gavrilovic Dusica,Minic Ivana Z,Ursulovic Tamara B,Dzodic Radan R (2018) The influence of breast cancer subtypes on the response to anthracycline neoadjuvant chemotherapy in locally advanced breast cancer patients, JOURNAL OF BUON, vol. 23, br. 5, str. 1273-1280 (Article) 

Bosnjak Snezana M,Stamatovic Ljiljana,Borroni Maria Elisa,Rizzi Giada,Jordan Karin (2018) Efficacy and Safety of Oral NEPA (Netupitant/Palonosetron), the First Fixed-Combination Antiemetic, in Patients With Gynecological Cancers Receiving Platinum-Based Chemotherapy, INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, vol. 28, br. 6, str. 1153-1161 (Article) 

Krivokuca Ana M,Dragos Vita Setrajcic,Stamatovic Ljiljana,Blatnik Ana,Boljevic Ivana Z,Stegel Vida,Rakobradovic Jelena D,Skerl Petra,Jovandic Stevo,Krajc Mateja,Brankovic-Magic Mirjana V,Novakovic Srdjan (2018) Novel BRCA1 splice-site mutation in ovarian cancer patients of Slavic origin, FAMILIAL CANCER, vol. 17, br. 2, str. 179-185 (Article) 

Popovic Lazar S,Tomasevic Zorica I,Stamatovic Ljiljana,Markovic Ivan Z,Matovina-Brko Gorana G,Buta Marko N,Golubovic Andrija,Selakovic Vladimir,Trifunovic Jasna D,Mutrezani Zafir,Ivanovic Nebojsa S,Nedovic Jasmina R,Ninkovic Srdjan M,Filipovic Sladjana,Cvetanovic Ana S,Djordjevic Nebojsa P,Karanikolic Aleksandar D,Ivkovic-Kapicl Tatjana V,Vicko Ferenc (2018) Serbian consensus of neoadjuvant therapy for breast cancer: NeoPULSE, JOURNAL OF BUON, vol. 23, br. 2, str. 522-532 (Article) 

Stamatovic Ljiljana,Vasovic Suzana,Trifunovic Jasna D,Boskov Nedeljka,Gajic Z,Parezanovic A,Icevic M,Cirkovic Andja M,Milic Natasa M (2018) Factors influencing time to seeking medical advice and onset of treatment in women who are diagnosed with breast cancer in Serbia, PSYCHO-ONCOLOGY, vol. 27, br. 2, str. 576-582 (Article) 

Susnjar Snezana V,Stamatovic Ljiljana,Gavrilovic Dusica,Minic Ivana Z,Ursulovic Tamara B (2017) The influence of breast cancer subtypes on response to anthracycline neoadjuvant chemotherapy in locally advanced breast cancer patients, BREAST, vol. 32, br. , str. S81-S82 (Meeting Abstract) 

Pljesa Igor,Berisavac Milica,Simic Tatjana P,Pekmezovic Tatjana D,Coric Vesna M,Suvakov Sonja R,Stamatovic Ljiljana,Matic Marija G,Gutic Bojana,Milenkovic Sanja M,Pljesa-Ercegovac Marija S,Savic-Radojevic Ana R (2017) Polymorphic expression of glutathione transferases A1, M1, P1 and T1 in epithelial ovarian cancer: a Serbian case-control study, JOURNAL OF BUON, vol. 22, br. 1, str. 72-79 (Article) 

Bosnjak Snezana M,Stamatovic Ljiljana,Jordan Karin,Rizzi Giada (2015) Prevention of Chemotherapy-Induced Nausea and Vomiting (Cinv) with Nepa, the First Oral Combination Antiemetic, in Patients with Gynecological Cancers Receiving Platinum-Based Chemotherapy, INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, vol. 25, br. 9, str. 582-583 (Meeting Abstract) 

Milovic-Kovacevic Marijana M,Susnjar Snezana V,Stamatovic Ljiljana (2015) Changing in Tumor Biology of Triple Negative Breast Cancer Between Primary and Metastatic Lesions, BREAST, vol. 24, br. , str. S70-S70 (Meeting Abstract) 

Stamatovic Ljiljana,Mamula-Masic SD,Vukotic Djordje,Kovac Zeljko,Mihailovic Z,Zdravkovic K,Petkovic Danijela,Bagi Teodora,Milic Natasa M (2014) Factors Influencing Time to Seeking Medical Advice and Treatment Onset in Breast Cancer Patients in Serbia, ANNALS OF ONCOLOGY, vol. 25, br. , str. - (Meeting Abstract) 

Jassem Jacek,Ozmen Vahit,Bacanu Florin,Drobniene Monika,Eglitis Janis,Lakshmaiah Kuntegowdanahalli C,Kahan Zsuzsanna,Mardiak Jozef,Pienkowski Tadeusz,Semiglazova Tatiana,Stamatovic Ljiljana,Timcheva Constanta,Vasovic Suzana,Vrbanec Damir,Zaborek Piotr (2014) Delays in diagnosis and treatment of breast cancer: a multinational analysis, EUROPEAN JOURNAL OF PUBLIC HEALTH, vol. 24, br. 5, str. 761-767 (Article) 

Stamatovic Ljiljana,Vasovic Suzana,Milovic-Kovacevic Marijana M,Karaferic Andjela,Lukic Vesna,Pupovac Simonida (2013) TOLERABILITY OF BEVACIZUMAB IN METASTATIC TRIPLE-NEGATIVE BREAST CANCER (TNBC) PATIENTS: A SINGLE INSTITUTION EXPERIENCE, BREAST, vol. 22, br. , str. S50-S51 (Meeting Abstract) 

Abu Rabi Zaki,Todorovic-Rakovic Natasa,Markicevic Milan A,Stamatovic Ljiljana,Vujasinovic Tijana,Nikolic-Vukosavljevic Dragica (2013) The significance of urokinase system in postmenopausal breast cancer patients, EUROPEAN JOURNAL OF CANCER, vol. 49, br. , str. S479-S479 (Meeting Abstract) 

Abu Rabi Zaki,Todorovic-Rakovic Natasa,Markicevic Milan A,Stamatovic Ljiljana,Vujasinovic Tijana,Nikolic-Vukosavljevic Dragica (2013) Change of influence of prognostic markers on metastasis free interval during and after adjuvant tamoxifen therapy in breast cancer patients, JOURNAL OF BUON, vol. 18, br. 2, str. 321-327 (Article) 

Susnjar Snezana V,Posarac Vladan,Milovanovic Zorka M,Milovic-Kovacevic Marijana M,Stamatovic Ljiljana,Gavrilovic Dusica,Karaferic Andjela (2013) Adjuvant Chemotherapy and Disease Outcome in Triple-Negative Breast Cancer: 3-Year Follow-Up Data, BREAST, vol. 22, br. , str. S93-S93 (Meeting Abstract) 

Jassem Jacek,Bacanu Florin,Eglitis Janis,Mardiak Jozef,Pienkowski Tadeusz,Kahan Zsuzsanna,Ozmen Vahit,Drobniene Monika,Vrbanec Damir,Semiglazova Tatyana,Stamatovic Ljiljana,Timcheva Constanta,Vasovic Suzana,Zaborek Piotr (2012) Patient-related factors influencing time between first signs of breast cancer (BC) and appointment for medical visit (AMV): An international survey, JOURNAL OF CLINICAL ONCOLOGY, vol. 30, br. 15, str. - (Meeting Abstract) 

Markicevic Milan A,Vujasinovic Tijana,Abu Rabi Zaki,Neskovic-Konstantinovic Zora B,Stamatovic Ljiljana,Nikolic-Vukosavljevic Dragica (2012) Postmenopausal Early Breast Cancer Patients - the Relevance of Quantitative ER Values and Follow-up Periods, EUROPEAN JOURNAL OF CANCER, vol. 48, br. , str. S214-S215 (Meeting Abstract) 

Susnjar Snezana V,Milovic-Kovacevic Marijana M,Karaferic Andjela,Stamatovic Ljiljana,Gavrilovic Dusica,Jovicevic Ana (2012) Triple-negative Breast Cancer - Which Classical Prognostic Factors Can Help in Identifying Patients with Early Relapse?, EUROPEAN JOURNAL OF CANCER, vol. 48, br. , str. S132-S132 (Meeting Abstract) 

Jassem Jacek,Ozmen Vahit,Bacanu Florin,Drobniene Monika,Eglitis Janis,Kahan Zsuzsanna,Lakshmaiah Kuntegowdanahalli C,Mardiak Jozef,Pienkowski Tadeusz,Semiglazova Tatiana,Stamatovic Ljiljana,Timcheva Constanta,Vasovic Suzana,Vrbanec Damir,Zaborek Piotr (2012) Factors influencing time to seeking medical advice and start of treatment in breast cancer (BC) patients - an International survey, CANCER RESEARCH, vol. 72, br. , str. - (Meeting Abstract) 

Radenkovic Sandra S,Konjevic Gordana M,Srdic Tatjana V,Stamatovic Ljiljana,Milovic Marijana M,Jurisic Vladimir B (2011) Association of Decreased NK Cell Activity and IFNgamma Expression With pSTAT Dysregulation in Breast Cancer Patients, EUROPEAN JOURNAL OF CANCER, vol. 47, br. , str. S362-S362 (Meeting Abstract) 

Konjevic Gordana M,Radenkovic Sandra S,Srdic Tatjana V,Jurisic Vladimir B,Stamatovic Ljiljana,Milovic Marijana M (2011) Association of decreased NK cell activity and IFN gamma expression with pSTAT dysregulation in breast cancer patients, JOURNAL OF BUON, vol. 16, br. 2, str. 219-226 (Article) 

Susnjar Snezana V,Karaferic Andjela,Milovic-Kovacevic Marijana M,Gavrilovic Dusica,Stamatovic Ljiljana,Milovanovic Zorka M,Jovicevic Ana (2011) Do medullar histology and type of adjuvant chemotherapy influence the short term outcome of triple negative early breast cancer patients?, BREAST, vol. 20, br. , str. S42-S42 (Meeting Abstract) 

Milovic-Kovacevic Marijana M,Susnjar Snezana V,Karaferic Andjela,Gavrilovic Dusica,Stamatovic Ljiljana,Milovanovic Zorka M,Jovicevic Ana (2011) Could the lack of expression of steroid receptors and HER2 discriminate a subgroup of triple negative breast cancer patients with poorer prognosis?, BREAST, vol. 20, br. , str. S40-S41 (Meeting Abstract) 

Milovic-Kovacevic Marijana M,Stamatovic Ljiljana,Popov Ivan P,Radosevic-Jelic Ljiljana M,Kezic Iva (2010) Platinum - sensitive relapsed epithelial ovarian cancer: Not all the patients benefit from reinduction with carboplatin and paclitaxel, MEDICAL SCIENCE MONITOR, vol. 16, br. 11, str. CR549-CR554 (Article) 

Vasovic Suzana,Stamatovic Ljiljana,Tomasevic Zoran M,Karaferic Andjela,Pavlovic L,Karadzic Katarina,Jovanic Irena P (2010) EVALUATION OF PROGNOSTIC VALUE OF HER2 AND VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF) EXPRESSION FOR PREDICTING EARLY FAILURE IN PATIENTS WITH OPERABLE BREAST CANCER, ANNALS OF ONCOLOGY, vol. 21, br. , str. 90-90 (Meeting Abstract) 

Abu Rabi Zaki,Markicevic Milan A,Vujasinovic Tijana,Lukic Silvana T,Stamatovic Ljiljana,Nikolic-Vukosavljevic Dragica (2010) Early and Late Tamoxifen Resistance in Breast Cancer, ARCHIVES OF BIOLOGICAL SCIENCES, vol. 62, br. 2, str. 249-256 (Article) 

Milovic Marijana M,Stamatovic Ljiljana,Vasovic Suzana,Karaferic Andjela,Jelic Svetislav B (2009) Platinum-sensitive relapsed epithelial ovarian cancer: how much does the treatment-free interval matter?, EJC SUPPLEMENTS, vol. 7, br. 2, str. 456-456 (Meeting Abstract) 

Vasovic Suzana,Stamatovic Ljiljana,Karaferic Andjela,Minic Ivana Z,Jelic Svetislav B,Gavrilovic Dusica (2008) Pac Regimen In Treatment of Recurrent Ovarian Cancer (Roc), ANNALS OF ONCOLOGY, vol. 19, br. , str. 215-216 (Meeting Abstract) 

Stamatovic Ljiljana,Vasovic Suzana,Karaferic Andjela,Tomasevic Zoran M,Jelic Svetislav B (2008) Capecitabine In Cisplatin-Pretreated Metastatic Or Recurrent Squamous Cell Carcinoma of The Cervix: A Possible Therapy Option For Obtaining Clinically Meaningful Outcome?, ANNALS OF ONCOLOGY, vol. 19, br. , str. 214-214 (Meeting Abstract) 

Susnjar Snezana V,Gavrilovic Dusica,Neskovic-Konstantinovic Zora B,Stamatovic Ljiljana,Ursulovic Tamara B (2007) Relationship of steroid receptor (SR) status and response to fluorouracil, doxorubicine and cyclophosphamide (FAC) primary systemic therapy (PST) in locally advanced breast cancer (LABC) patients, BREAST, vol. 16, br. , str. S52-S53 (Meeting Abstract) 

Tomasevic Zorica I,Jovanovic Danica,Radosevic-Jelic Ljiljana M,Tomasevic Zoran M,Vasovic Suzana,Stamatovic Ljiljana,Jelic Svetislav B,Spasic Jelena R (2006) HER-2 status of the primary breast cancer in patients with late disease relapse, ANNALS OF ONCOLOGY, vol. 17, br. , str. 89-89 (Meeting Abstract) 

Tomasevic Zorica I,Jelic Svetislav B,Nikolic L,Filipovic I,Stamatovic Ljiljana,Radosavljevic Davorin Z (2003) Negative CEA values in metastatic colorectal carcinoma and the likelihood of complete chemotherapy response, INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, vol. 18, br. 1, str. 28-32 (Article) 

Jelic Svetislav B,Stamatovic Ljiljana,Vucicevic Slavko S,Petrovic Zeljko M,Kreacic Miroslav,Babovic Nada Lj,Jovanovic Natasa,Mikic Anton A,Gavrilovic Dusica (2002) Use of high-dose cytarabine to enhance cisplatin cytotoxicity - effects on the response and overall survival rates of advanced head and neck cancer patients, EUROPEAN JOURNAL OF CANCER, vol. 38, br. 11, str. 1478-1489 (Article) 

Stamatovic Ljiljana,Jelic Svetislav B,Susnjar Snezana V,Vasovic Suzana,Nikolic-Tomasevic Zorica I,Neskovic-Konstantinovic Zora B (2002) Salvage capecitabine-leucovorine-vinorelbine combination chemotherapy in both anthracycline and taxane resistant metastatic breast cancer, EUROPEAN JOURNAL OF CANCER, vol. 38, br. , str. S74-S74 (Meeting Abstract) 

Tomasevic Zorica I,Jelic Svetislav B,Vasovic Suzana,Stamatovic Ljiljana,Radosavljevic Davorin Z (2002) Values of serum alkaline phosphatase could be useful in rational selection of metastatic breast cancer (MBC) with tumor induced hypercalcemia (TIH) for bisphosphonates treatment, BONE, vol. 30, br. 3, str. 53S-53S (Meeting Abstract) 

Jelic Svetislav B,Babovic Nada Lj,Stamatovic Ljiljana,Kreacic Miroslav,Matkovic Suzana V,Popov Ivan P (2001) Vinblastin-carboplatin for metastatic cutaneous melanoma as first-line chemotherapy and in dacarbazine failures - A single-center study, MEDICAL ONCOLOGY, vol. 18, br. 3, str. 189-195 (Article) 

Jelic Svetislav B,Babovic Nada Lj,Stamatovic Ljiljana,Vucicevic Slavko S,Pendjer Ivica P,Radulovic Sinisa S (2000) Paclitaxel-cisplatin as first line chemotherapy for undifferentiated carcinoma of the nasopharynx (UCNT): A preliminary report., ANNALS OF ONCOLOGY, vol. 11, br. , str. 93-93 (Meeting Abstract) 

Babovic Nada Lj,Jelic Svetislav B,Stamatovic Ljiljana (2000) Cisplatin dose intensity in poor risk germ cell tumors., ANNALS OF ONCOLOGY, vol. 11, br. , str. 77-77 (Meeting Abstract) 

Radosavljevic Davorin Z,Jelic Svetislav B,Babovic Nada Lj,Popov Ivan P,Kreacic Miroslav,Stamatovic Ljiljana,Nikolic-Tomasevic Zorica I,Kezic Iva (2000) Addition of medroxyprogesterone-acetate (MPA) to interferon-alpha (IFN) vinblastine (VLB) combination in advanced renal-cell carcinoma (RCC) - is there any impact on quality of life (QoL)?, ANNALS OF ONCOLOGY, vol. 11, br. , str. 75-75 (Meeting Abstract) 

Stamatovic Ljiljana,Jelic Svetislav B,Susnjar Snezana V,Vasovic Suzana (2000) Docetaxel-mitomycin-vinblastine combination chemotherapy in patients with anthracycline-resistant advanced breast cancer (ABC): An interim report., ANNALS OF ONCOLOGY, vol. 11, br. , str. 27-27 (Meeting Abstract) 

Susnjar Snezana V,Vasovic Suzana,Neskovic-Konstantinovic Zora B,Stamatovic Ljiljana,Lukic Vesna,Colakovic Slobodanka,Mitrovic LB,Jelic Svetislav B,Radulovic Sinisa S (1999) Mitoxantrone, 5-fluorouracil and low-dose leucovorin in doxorubicin-resistant advanced breast cancer patients: A phase II study, TUMORI, vol. 85, br. 6, str. 478-482 (Article)